Richter, S.; Seah, J.-A.; Pond, G. R.; Gan, H. K.; Mackenzie, M. J.; Hotte, S. J.; Mukherjee, S. D.; Murray, N.; Kollmannsberger, C.; Heng, D.; Haider, M. A.; Halford, R.; Ivy, S. P.; Moore, M. J.; Sridhar, S. S. Evaluation of Second Line and Subsequent Targeted Therapies in Metastatic Renal Cell Cancer (mRCC) Patients Treated With First Line Cediranib. CUAJ 2014, 8, 398-402.